relapsing forms of multiple sclerosis

GPTKB entity

Statements (59)
Predicate Object
gptkbp:instance_of gptkb:multiple_sclerosis
gptkbp:affects central nervous system
gptkbp:can_lead_to disability
cognitive impairment
mobility issues
relapses
gptkbp:caused_by autoimmune response
gptkbp:diagnosis gptkb:MRI
variable
neurological examination
gptkbp:has_achieved gptkb:depression
secondary infections
gptkbp:has_type gptkb:relapsing-remitting_multiple_sclerosis
gptkb:secondary_progressive_multiple_sclerosis
https://www.w3.org/2000/01/rdf-schema#label relapsing forms of multiple sclerosis
gptkbp:impact quality of life
gptkbp:is_affected_by stress
temperature changes
gptkbp:is_associated_with rehabilitation programs
chronic pain
inflammation
demyelination
fatigue management strategies
gptkbp:is_characterized_by periods of remission
exacerbations
periods of relapse
remissions
gptkbp:is_common_in gptkb:women
young adults
gptkbp:is_documented_in gptkb:literature
gptkb:guidelines
gptkbp:is_managed_by physical therapy
lifestyle changes
symptomatic treatment
primary care physicians
neurologists
gptkbp:is_monitored_by regular check-ups
neurological assessments
gptkbp:is_often_seen_in psychological conditions
other neurological disorders
gptkbp:is_part_of multiple sclerosis spectrum disorders
gptkbp:is_related_to environmental factors
genetic factors
gptkbp:is_studied_for new treatment options
long-term outcomes
gptkbp:is_studied_in clinical trials
gptkbp:is_supported_by research funding
patient advocacy groups
gptkbp:symptoms fatigue
vision problems
weakness
numbness
cognitive changes
gptkbp:treatment gptkb:immunotherapy
corticosteroids
plasma exchange
disease-modifying therapies
gptkbp:bfsParent gptkb:Ocrevus
gptkbp:bfsLayer 5